lead product candidate,0.321664
clinical-stage biopharmaceutical company,0.334542
strong buy rating,0.479814
stock,0.156383
hold rating,0.553197
insider Albert Robichaud,-0.264365
InvestorPlace Broker Center,0.555736
Therapeutics Inc Daily,0.487375
high fees,-0.735674
research report,-0.242241
biopharmaceutical company,0.105222
major depressive disorder,-0.680015
12-month high,-0.308991
hedge funds,-0.205614
Hershey Trust Company,0.378898
Zacks Investment Research,0.40995
personal trading style,0.598412
status epilepticus,0.321664
Leerink Swann,-0.242241
target price,0.0953078
average rating,-0.253601
research offerings,0.40995
average price,0.144131
shares,0.134948
concise daily summary,0.531991
consensus target price,0.440552
Marketbeat.com reports,-0.286455
SAGE Therapeutics Inc.,-0.280328
stock broker,0.245696
SAGE Therapeutics,0.193928
brain injury conditions,-0.454544
quarter,0.378898
